U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07416318) titled 'Unveiling the Protein Expression Patterns in Oral Lichen Planus and Leukoplakia Through Com... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417085) titled 'MICRO-BRAIN 2024: Study on Pediatric Brain Tumors' on Feb. 02. Brief Summary: In recent ye... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418112) titled 'Comparing the Efficacy and Safety of Holmium Laser Lithotripsy Versus Electrohydraulic Lith... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417878) titled 'Study of the Nutritional, Inflammatory, and Metabolic Endophenotypes of Attention-Deficit/H... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417189) titled 'A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )' on Ja... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417774) titled 'Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic' on Feb... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07416253) titled 'Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positi... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418892) titled 'Effects of Resisted Versus Unresisted Sprint Training on Sprint Force-Velocity Profile in Y... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417501) titled 'Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification' on Feb. ... Read More
U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07416409) titled 'Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian... Read More